J&J agrees to sell LifeScan to Platinum Equity

13 June 2018 - Deborah Wilkes

Archived

Johnson & Johnson has agreed to sell its LifeScan blood glucose monitoring business to private-equity firm Platinum Equity for around USD2.1 billion.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: